Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Vomiting 6Postoperative Nausea and Vomiting 3Neoplasms 3Prostatic Neoplasms 1Pain, Postoperative 1Ovarian Neoplasms 1Nausea 1Myofibroma 1Lung Neoplasms 1Hematologic Neoplasms 1Colonic Neoplasms 1Agnosia 1Adenomyosis 1

Interventions

Cyclophosphamide 87fludarabine 77fludarabine phosphate 45Tacrolimus 45Whole-Body Irradiation 42Mycophenolic Acid 42Busulfan 35Melphalan 32Antilymphocyte Serum 24Methotrexate 23thymoglobulin 22Standard of Care 22Rituximab 22venetoclax 20Thiotepa 20Sirolimus 20Azacitidine 20Stem Cell Transplantation 18Granulocyte Colony-Stimulating Factor 18Practice Guidelines as Topic 17Cytarabine 16Bortezomib 16Nivolumab 15Filgrastim 15Specimen Handling 14Dexamethasone 14Blood Specimen Collection 14Cyclosporine 13Surveys and Questionnaires 12Mesna 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × ramosetron × Clear all
NCT01788605 2014-12-08

Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation

The Catholic University of Korea

Phase 2 Unknown
65 enrolled
Other hematologic neoplasm

Vomiting, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡